| For: | Urquijo-Ponce JJ, Alventosa-Mateu C, Latorre-Sánchez M, Castelló-Miralles I, Diago M. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma. World J Gastroenterol 2024; 30(19): 2512-2522 [PMID: 38817666 DOI: 10.3748/wjg.v30.i19.2512] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i19/2512.htm |
| Number | Citing Articles |
| 1 |
Amani E. Marawan, Omar Ahmed Elmetwally, Mohamed M. Marwan, Mohamed M. A. El-Sokkary, Shimaa A. Abass, Laila A. Eissa. Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-28663-6
|
| 2 |
Wei Xu, Huai Gong, Bolun Li, Xinmin Yin. Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241289202
|
| 3 |
Xiao-Dong Zhang, Lu-Yi Zhang, Jia-Liang Luo, Ke-Heng Yu, Ke-Lei Zhu. Neoadjuvant therapy: Dawn of reducing the high post-surgery recurrence rate of hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2025; 17(3): 103740 doi: 10.4240/wjgs.v17.i3.103740
Abstract(374) |
Core Tip(341) |
Full Article(HTML)(1470)
|
Full Article with Cover (PDF)-1245K(107)
|
Audio-290K(4)
|
Peer-Review Report-236K(70)
|
Answering Reviewers-122K(75)
|
Supplementary Material-127K(71)
|
Full Article (PDF)-951K(118)
|
Full Article (XML)-212K(79)
|
Times Cited (0)
|
Total Visits (5160)
|
Open
|
| 4 |
Jun Pu, Yamin Zhao, Siming Zhang, Tianqi Wu, Ruizi Liu, Tianyi Yuan, Songnian He, Qingyu Hao, Haixia Zhu. Mapping the knowledge domains of literature on hepatocellular carcinoma and liver failure: a bibliometric approach. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1529297
|
| 5 |
Carlos Alventosa-Mateu, Juan José Urquijo Ponce. Present and future of systemic therapy for early and intermediate stages of hepatocellular carcinoma. Revisiones en Cáncer 2025; doi: 10.20960/revcancer.00104
|
| 6 |
Mohammad Sadegh Izadi, Reza Arefnezhad, Amirmasoud Asadi, Aryan Rezaee, Leila Kalantari, Farzad Nasrpour Tahouneh, Mohammad Mehdi Shadravan, Seyyed Taher Seyyed Mahmoudi, Zahra GhaniBeygi, Fatemeh Rostamnezhad, Armin Razman, Fardad Ejtehadi, Fatemeh Rezaei-Tazangi, Marziye Ranjbar Tavakoli. Molecular and cellular secrets revealed: How umbilical cord-derived mesenchymal stem cells can target hepatocellular carcinoma. Tissue and Cell 2026; 98: 103200 doi: 10.1016/j.tice.2025.103200
|
| 7 |
Vladislav V Tsukanov, Julia L Tonkikh, Edward V Kasparov, Alexander V Vasyutin. Inhibition of M2 tumor-associated macrophages polarization by modulating the Wnt/β-catenin pathway as a possible liver cancer therapy method. World Journal of Gastroenterology 2024; 30(40): 4399-4403 doi: 10.3748/wjg.v30.i40.4399
|
| 8 |
Erik Cressman, Danielle Stolley, Natalie Fowlkes, Edd Felix, Waldemar Priebe, Steve Parrish, David Fuentes. Harnessing Electrophiles In Vivo: A Pilot Study in Swine Using a Hydrophobic Radiopaque Formulation of 2-Propylpentanoyl Chloride. Molecular Pharmaceutics 2025; 22(6): 3010 doi: 10.1021/acs.molpharmaceut.4c01456
|
| 9 |
Luca Tirloni, Ilenia Bartolini, Carlo Gazia, Andrea Scarinci, Gian Luca Grazi. A contemporary view on vascular resections and reconstruction during hepatectomies. Updates in Surgery 2024; 76(5): 1643 doi: 10.1007/s13304-024-01934-z
|
